ER-Positive mBC 19


Manage episode 234967819 series 16667
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Dissecting the Decision: Optimizing the Use of CDK4/6 Inhibitors in the Management of ER-Positive, HER2-Negative Metastatic Breast Cancer. Featuring a roundtable discussion with Drs Neelima Denduluri, Shom Goel, Erika Hamilton, Komal Jhaveri, Ruth M O’Regan and Sara M Tolaney. Moderated by Neil Love, MD. Produced by Research To Practice.

382 episodes available. A new episode about every 35 days averaging 57 mins duration .